drugging variability to create drugs that work on all patients

Is there a way to turn a $40B/yr class of drugs that only works on about half of patients into a drug that works for all patients? We think the answer is YES.

Three years ago we set out on…

Atray Dixit

CEO@Coral: patient diversity + improving therapies. MIT PhD 2018: single cell seq + CRISPR (Perturb-seq, Shuffle-seq)

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store